Skyline Venture Partners V LP
Insider CIK 1419187 · COLL 10% owner · STRO 10% owner · DRNA 10% owner · SIBN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SIBN SI-BONE, Inc. | S Sale | 2020-01-27 | 2020-08-14 | 1,000,000 | $21.50 | $21.50M | 2,819,985 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-26 | 2019-08-27 | 152,424 | $18.40 | $2.80M | 3,819,985 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-23 | 2019-08-23 | 180 | $20.03 | $3.6K | 3,972,409 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-22 | 2019-08-23 | 2,185 | $20.05 | $43.8K | 3,972,589 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-21 | 2019-08-23 | 18,144 | $20.17 | $366.0K | 3,974,774 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-21 | 2019-08-23 | 27,067 | $20.14 | $545.1K | 3,992,918 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-12 | 2019-08-14 | 400,000 | $18.25 | $7.30M | 4,019,985 | SEC↗ |
| SIBN SI-BONE, Inc. | X Exercise deriv | 2018-10-19 | 2018-10-19 | 39,421 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | X Exercise deriv | 2018-10-19 | 2018-10-19 | 39,421 | — | $0 | 816,099 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale deriv | 2018-10-19 | 2018-10-19 | 23,904 | $14.00 | $334.7K | 792,195 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 2,213,425 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 792,195 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 652,347 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 398,676 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 792,195 | — | $0 | 3,005,620 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 2,213,425 | — | $0 | 2,213,425 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 690,689 | — | $0 | 3,696,309 | SEC↗ |
| SIBN SI-BONE, Inc. | P Buy | 2018-10-19 | 2018-10-19 | 325,000 | $15.00 | $4.88M | 4,419,985 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 398,676 | — | $0 | 4,094,985 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-03 | 18,698,578 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-03 | 12,846,023 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-03 | 25,015,635 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-03 | 925,578 | — | $0 | 925,578 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-03 | 520,264 | — | $0 | 1,445,842 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-03 | 514,211 | — | $0 | 1,960,053 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2017-12-05 | 2017-12-07 | 800,000 | — | $0 | 2,149,916 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-13 | 5,881,724 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-13 | 2,638,030 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-13 | 10,714,286 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-13 | 382,323 | — | $0 | 1,935,118 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-13 | 864,798 | — | $0 | 2,799,916 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | P Buy | 2015-05-12 | 2015-05-13 | 150,000 | $12.00 | $1.80M | 2,949,916 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-13 | 1,552,795 | — | $0 | 1,552,795 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2015-02-20 | 2015-02-24 | 37,532 | $26.02 | $976.6K | 1,719,671 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 179,322 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 312,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 21,697 | — | $0 | 21,697 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 1,043,429 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 21,697 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 755 | — | $0 | 755 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-05 | 200,000 | $15.00 | $3.00M | 1,734,751 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 312,000 | — | $0 | 312,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 1,043,429 | — | $0 | 1,534,751 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 179,322 | — | $0 | 491,322 | SEC↗ |